Chronic exposure to arsenite enhances influenza virus infection in cultured cells
AffiliationUniv Arizona, Coll Pharm, Dept Pharmacol & Toxicol
Univ Arizona, Coll Vet Med
MetadataShow full item record
CitationAmouzougan, E. A., Lira, R., & Klimecki, W. T. (2020). Chronic exposure to arsenite enhances influenza virus infection in cultured cells. Journal of Applied Toxicology. https://doi.org/10.1002/jat.3918
JournalJOURNAL OF APPLIED TOXICOLOGY
RightsCopyright © 2020 John Wiley & Sons, Ltd.
Collection InformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at email@example.com.
AbstractArsenic is a ubiquitous environmental toxicant that has been associated with human respiratory diseases. In humans, arsenic exposure has been associated with increased risk of respiratory infection. Considering the existing epidemiological evidence and the well-established impact of arsenic on epithelial cell biology, we posited that the effect of arsenic exposure in epithelial cells could enhance viral infection. In this study, we characterized influenza virus A/WSN/33 (H1N1) infection in Madin-Darby Canine Kidney (MDCK) cells chronically exposed to low levels of sodium arsenite (75 ppb). We observed a 27.3-fold increase in viral matrix (M2) protein (24 hours postinfection [p.i.]), a 1.35-fold increase in viral mRNA levels, and a 126% increase in plaque area in arsenite-exposed MDCK cells (48 hours p.i.). Arsenite exposure resulted in 114% increase in virus attachment-positive cells (2 hours p.i.) and 224% increase in alpha-2,3 sialic acid-positive cells. Interestingly, chronic exposure to arsenite reduced the effect of the antiviral drug, oseltamivir in MDCK cells. We also found that exposure to sodium arsenite resulted in a 4.4-fold increase in viral mRNA levels and significantly increased cytotoxicity in influenza A/Udorn/72 (H3N2) infected BEAS-2B cells. This study suggests that chronic arsenite exposure could result in enhanced influenza infection in epithelial cells, and that this may be mediated through increased sialic acid binding. Finally, the decreased effectiveness of the anti-influenza drug, oseltamivir, in arsenite-exposed cells raises substantial public health concerns if this effect translates to arsenic-exposed, influenza-infected people.
Note12 month embargo; published online: 20 January 2020
VersionFinal accepted manuscript
- MDCK-B4GalNT2 cells disclose a α2,3-sialic acid requirement for the 2009 pandemic H1N1 A/California/04/2009 and NA aid entry of A/WSN/33.
- Authors: Wong HH, Fung K, Nicholls JM
- Issue date: 2019
- Analysis of cytokine production in a newly developed canine tracheal epithelial cell line infected with H3N2 canine influenza virus.
- Authors: Park WJ, Park BJ, Song YJ, Lee DH, Yuk SS, Lee JB, Park SY, Song CS, Lee SW, Choi IS
- Issue date: 2015 Jun
- Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor.
- Authors: Sidwell RW, Huffman JH, Barnard DL, Bailey KW, Wong MH, Morrison A, Syndergaard T, Kim CU
- Issue date: 1998 Feb
- In vitro evaluation of synergistic inhibitory effects of neuraminidase inhibitors and methylglyoxal against influenza virus infection.
- Authors: Charyasriwong S, Watanabe K, Rahmasari R, Matsunaga A, Haruyama T, Kobayashi N
- Issue date: 2015 Jan
- Effect of aloin on viral neuraminidase and hemagglutinin-specific T cell immunity in acute influenza.
- Authors: Huang CT, Hung CY, Hseih YC, Chang CS, Velu AB, He YC, Huang YL, Chen TA, Chen TC, Lin CY, Lin YC, Shih SR, Dutta A
- Issue date: 2019 Nov